Anus Cancer

Categories: Cancer diseases, Gastrointestinal diseases, Immune diseases, Rare diseases

Aliases & Classifications for Anus Cancer

MalaCards integrated aliases for Anus Cancer:

Name: Anus Cancer 12 15
Anal Cancer 12 53 43
Anus Neoplasms 44 73
Anus Neoplasm 12 15
Malignant Neoplasm of Anus 73
Malignant Anal Tumor 12
Cancer of the Anus 53
Neoplasm of Anus 12
Anal Carcinoma 73
Anal Neoplasm 12
Anal Tumors 12


External Ids:

Disease Ontology 12 DOID:14110 DOID:4551
ICD10 33 C21.0 C21.1
ICD9CM 35 154.2 154.3
NCIt 50 C7379 C2877
SNOMED-CT 68 93669004 93676009
MeSH 44 D001005

Summaries for Anus Cancer

NIH Rare Diseases : 53 Anal cancer is a rare form of cancer that occurs due to abnormal and uncontrolled cell growth in the anus. Signs and symptoms of the condition include rectal bleeding; a lump in or near the anus; anal pain; itching; changes in bowel habits; and/or swollen lymph nodes. In most cases, the underlying cause of anal cancer is unknown. There appears to be a link between anal cancer and the human papillomavirus (HPV) infection. Other risk factors for anal cancer include HIV infection, sexual activity, smoking, and a weakened immune system. The best treatment options for anal cancer depend on many factors including the stage of the condition, the location of the tumor and if there are associated conditions (i.e. HIV) but may include surgery, chemotherapy, and radiation therapy.

MalaCards based summary : Anus Cancer, also known as anal cancer, is related to anal canal adenocarcinoma and anal canal squamous cell carcinoma, and has symptoms including nausea and vomiting, constipation and abdominal pain. An important gene associated with Anus Cancer is SERPINB3 (Serpin Family B Member 3). The drugs Gardasil and Oxaliplatin have been mentioned in the context of this disorder. Affiliated tissues include testes, lymph node and skin.

Disease Ontology : 12 A large intestine cancer that is located in the anus.

MedlinePlus : 43 The anus is where stool leaves your body when you go to the bathroom. It is made up of your outer layers of skin and the end of your large intestine. Anal cancer is a disease in which cancer cells form in the tissues of the anus. Anal cancer is rare. It is more common in smokers and people over 50. You are also at higher risk if you have HPV, have anal sex, or have many sexual partners. Symptoms include bleeding, pain, or lumps in the anal area. Anal itching and discharge can also be signs of anal cancer. Doctors use tests that examine the anus to diagnose anal cancer. They include a physical exam, endoscopy, ultrasound, and biopsy. Treatments include radiation therapy, chemotherapy, and surgery. NIH: National Cancer Institute

Wikipedia : 76 Anal cancer is a cancer (malignant tumor) which arises from the anus, the distal opening of the... more...

Related Diseases for Anus Cancer

Diseases related to Anus Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 152)
# Related Disease Score Top Affiliating Genes
1 anal canal adenocarcinoma 30.4 CDX2 KRT7
2 anal canal squamous cell carcinoma 30.3 CDKN2A KRT5 SERPINB3
3 papilloma 30.0 CDKN2A KRT5 KRT7
4 anal canal carcinoma 30.0 CD6 CDKN2A KRT7 SLC14A2
5 rectal neoplasm 29.5 DCXR KRT7 SLC14A2 SMUG1
6 anus disease 29.3 CDKN2A DCXR SERPINB3 SMUG1
7 hemorrhoid 11.3
8 anus sarcoma 11.0
9 vulva squamous cell carcinoma 10.3 CDKN2A SERPINB3
10 vulval paget's disease 10.2 CDKN2A KRT7
11 adenoid basal cell carcinoma 10.2 CDKN2A KRT7
12 bile duct adenoma 10.2 CDKN2A KRT7
13 endocervical carcinoma 10.2 CDKN2A KRT7
14 bladder carcinoma in situ 10.2 CDKN2A KRT7
15 glycogen-rich clear cell breast carcinoma 10.2 CDKN2A KRT7
16 well-differentiated liposarcoma 10.2 CDKN2A KRT7
17 ovary neuroendocrine neoplasm 10.2 CDX2 KRT7
18 appendix adenocarcinoma 10.2 CDX2 KRT7
19 mucinous adenofibroma 10.2 CDX2 KRT7
20 anus adenocarcinoma 10.2 CDX2 KRT7
21 glandular cystitis 10.2 CDX2 KRT7
22 optic nerve sheath meningioma 10.2 CDKN2A KRT5
23 keratinizing squamous cell carcinoma 10.2 CDKN2A KRT5
24 duodenum adenocarcinoma 10.2 CDX2 KRT7
25 epithelial predominant wilms' tumor 10.2 CDX2 KRT7
26 basaloid squamous cell carcinoma 10.2 CDKN2A KRT7
27 cervical adenosquamous carcinoma 10.2 CDKN2A KRT7
28 ovarian mucinous adenocarcinoma 10.2 CDX2 KRT7
29 thymus adenocarcinoma 10.2 CDX2 KRT7
30 balloon cell malignant melanoma 10.2 KRT5 KRT7
31 appendix disease 10.2 CDX2 KRT7
32 benign breast adenomyoepithelioma 10.2 KRT5 KRT7
33 breast adenomyoepithelioma 10.2 KRT5 KRT7
34 gastric diffuse adenocarcinoma 10.2 CDX2 KRT7
35 ceruminoma 10.2 KRT5 KRT7
36 lymphoepithelioma-like thymic carcinoma 10.2 CDKN2A KRT5
37 bladder adenocarcinoma 10.2 CDX2 KRT7
38 benign mesothelioma 10.2 KRT5 KRT7
39 chronic cystitis 10.2 CDX2 KRT7
40 sensory organ benign neoplasm 10.2 KRT5 KRT7
41 bile duct mucoepidermoid carcinoma 10.2 KRT5 KRT7
42 middle ear adenoma 10.2 KRT5 KRT7
43 mucinous ovarian cystadenoma 10.2 CDX2 KRT7
44 large cell acanthoma 10.2 KRT5 KRT7
45 apocrine sweat gland neoplasm 10.2 KRT5 KRT7
46 ampulla of vater adenocarcinoma 10.2 CDX2 KRT7
47 biliary papillomatosis 10.2 CDX2 KRT7
48 duodenal disease 10.2 CDX2 KRT7
49 malignant biphasic mesothelioma 10.2 KRT5 KRT7
50 ovarian mucinous neoplasm 10.2 CDX2 KRT7

Comorbidity relations with Anus Cancer via Phenotypic Disease Network (PDN):

Acute Cystitis Deficiency Anemia
Rectal Neoplasm

Graphical network of the top 20 diseases related to Anus Cancer:

Diseases related to Anus Cancer

Symptoms & Phenotypes for Anus Cancer

UMLS symptoms related to Anus Cancer:

nausea and vomiting, constipation, abdominal pain, diarrhea, icterus, dyspepsia, heartburn, pruritus ani, gastrointestinal gas

Drugs & Therapeutics for Anus Cancer

FDA approved drugs:

# Drug Name Active Ingredient(s) 18 Company Approval Date
Gardasil 18 49 quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine Merck June 2006

Drugs for Anus Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 148)
# Name Status Phase Clinical Trials Cas Number PubChem Id
Oxaliplatin Approved, Investigational Phase 4,Phase 2,Phase 1 61825-94-3 43805 6857599 5310940 9887054
2 Immunologic Factors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
3 Immunoglobulins Phase 4,Phase 2,Phase 1
4 Antibodies Phase 4,Phase 2,Phase 1
5 Vaccines Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
6 Cola Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
7 Liver Extracts Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
8 Pharmaceutical Solutions Phase 4,Not Applicable
Cisplatin Approved Phase 3,Phase 2,Phase 1 15663-27-1 2767 441203 84093
Fluorouracil Approved Phase 3,Phase 2,Phase 1,Early Phase 1 51-21-8 3385
Paclitaxel Approved, Vet_approved Phase 3,Phase 2,Phase 1 33069-62-4 36314
Octreotide Approved, Investigational Phase 3 83150-76-9 383414 6400441
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
Capecitabine Approved, Investigational Phase 3,Phase 2,Phase 1 154361-50-9 60953
Imiquimod Approved, Investigational Phase 3 99011-02-6 57469
16 Pancreatic Polypeptide Investigational Phase 3,Phase 1 59763-91-6
17 Immunosuppressive Agents Phase 3,Phase 2,Phase 1,Early Phase 1
18 Antimetabolites Phase 3,Phase 2,Phase 1,Early Phase 1
19 Antimetabolites, Antineoplastic Phase 3,Phase 2,Phase 1,Early Phase 1
20 Anesthetics Phase 3,Phase 1,Not Applicable
21 interferons Phase 3,Phase 2,Phase 1
22 Antineoplastic Agents, Phytogenic Phase 3,Phase 2,Phase 1
23 Antimitotic Agents Phase 3,Phase 2,Phase 1
24 Albumin-Bound Paclitaxel Phase 3,Phase 2,Phase 1
25 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 2,Phase 1,Early Phase 1
26 Mitomycins Phase 3,Phase 2,Phase 1,Early Phase 1
27 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1,Early Phase 1
28 Alkylating Agents Phase 3,Phase 2,Phase 1,Early Phase 1
29 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1,Early Phase 1
30 Gastrointestinal Agents Phase 3
31 Antineoplastic Agents, Hormonal Phase 3
32 Central Nervous System Depressants Phase 3,Phase 2
33 Adjuvants, Anesthesia Phase 3
34 Anesthetics, Intravenous Phase 3
35 Analgesics, Opioid Phase 3
36 Peripheral Nervous System Agents Phase 3,Phase 2
37 Anesthetics, General Phase 3
38 Analgesics Phase 3,Phase 2
39 Narcotics Phase 3
40 Adjuvants, Immunologic Phase 3,Phase 1
41 Interferon Inducers Phase 3
Cetuximab Approved Phase 2,Phase 1 205923-56-4 56842117 2333
Carboplatin Approved Phase 2,Phase 1 41575-94-4 10339178 38904 498142
Ritonavir Approved, Investigational Phase 2 155213-67-5 392622
Indinavir Approved Phase 2 150378-17-9 5362440
Formaldehyde Approved, Vet_approved Phase 2 50-00-0 712
Cidofovir Approved Phase 2 113852-37-2 60613
Cyclophosphamide Approved, Investigational Phase 1, Phase 2,Phase 2 6055-19-2, 50-18-0 2907
Fludarabine Approved Phase 1, Phase 2,Phase 2 75607-67-9, 21679-14-1 30751
Aldesleukin Approved Phase 1, Phase 2,Phase 2 85898-30-2, 110942-02-4

Interventional clinical trials:

(show top 50) (show all 194)
# Name Status NCT ID Phase Drugs
1 Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients Unknown status NCT02624349 Phase 4 Quadravalent human papillomavirus vaccine
2 Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer Unknown status NCT00274885 Phase 4 oxaliplatin
3 Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study Recruiting NCT01824537 Phase 4
4 Scientific Evaluation of One or Two Doses of the Bivalent or Nonavalent Prophylactic HPV Vaccines Recruiting NCT03180034 Phase 4
5 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer Unknown status NCT00003652 Phase 3 cisplatin;fluorouracil
6 Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer Completed NCT00025090 Phase 3 cisplatin;fluorouracil;mitomycin C
7 Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer Completed NCT00003596 Phase 3 cisplatin;fluorouracil;mitomycin C
8 Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia Completed NCT01164722 Phase 3
9 An Investigational Study of Gardasil™ (qHPV Vaccine) in Reducing the Incidence of Anogenital Warts in Young Men (V501-020) Completed NCT00090285 Phase 3
10 Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003) Completed NCT01651949 Phase 3
11 Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer Completed NCT00075868 Phase 3 octreotide acetate
12 Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women Completed NCT01461096 Phase 3
13 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
14 Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions Recruiting NCT02135419 Phase 3 imiquimod;fluorouracil
15 Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy Recruiting NCT02369939 Phase 3 Mitomycin C;5-Fluorouracil
16 Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery Recruiting NCT02997553 Phase 3 Indocyanine green;Technetium99
17 Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients Enrolling by invitation NCT02526953 Phase 3 Paclitaxel;Capecitabine;Capecitabine;Mitomycins;Mitomycins
18 Immunogenicity From 1 Dose of Bivalent HPV Vaccine in Girls to 3 Doses of Quadrivalent Vaccine in Women: the PRIMAVERA-ESCUDDO Trial Not yet recruiting NCT03728881 Phase 3
19 Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer Terminated NCT00068744 Phase 2, Phase 3 cisplatin;fluorouracil;mitomycin C
20 Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer Unknown status NCT00955240 Phase 2 cisplatin;fluorouracil
21 International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly Paclitaxel Unknown status NCT02051868 Phase 2 Cisplatin;5-Fluorouracil (5-FU);Carboplatin;Paclitaxel
22 A Phase II Study to Assess Acute Toxicity and Quality of Life of Patients With Carcinoma of the Anal Canal Receiving Chemotherapy and Radiation Using Helical Tomotherapy Unknown status NCT00754078 Phase 2
23 External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Unknown status NCT00637637 Phase 2 indinavir sulfate;ritonavir
24 Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer Completed NCT00324415 Phase 2 cisplatin;fluorouracil
25 SGN-00101 in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia Completed NCT00052897 Phase 1, Phase 2
26 Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer Completed NCT00423293 Phase 2 fluorouracil;mitomycin C
27 Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer Completed NCT00093379 Phase 2 Capecitabine;Oxaliplatin
28 Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus Completed NCT00550589 Phase 2 cidofovir
29 Vectibix for the Treatment of Anal Cancer Completed NCT01285778 Phase 2 panitumumab, mytomicin C, 5-FU, radiation
30 Treatment of Anal High-grade Squamous Intraepithelial Lesions (HSIL) Through Use of a Chinese Herbal Topical Cream Completed NCT00622440 Phase 2 AIJP (Arnebia Indigo Jade Pearl);Placebo
31 Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men Completed NCT00428285 Phase 2
32 Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males Completed NCT01209325 Phase 2
33 Erlotinib in Treating Patients With Advanced Kidney Cancer Completed NCT00045487 Phase 2 OSI-774
34 A Study of Substitution of 5-FU (Fluorouracil) by Capecitabine in Scheme of Chemo-radiotherapy in Patients With Squamous Cell Carcinoma of the Anal Canal. Completed NCT01941966 Phase 2 Capecitabine;Mitomycins
35 T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers Completed NCT02280811 Phase 1, Phase 2 Fludarabine;Cyclophosphamide;Aldesleukin
36 Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers Completed NCT01585428 Phase 2 Fludarabine;Cyclophosphamide;Aldesleukin
37 [F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers Completed NCT01717391 Phase 2 fluorothymidine F 18
38 Oral Rigosertib for Squamous Cell Carcinoma Completed NCT01807546 Phase 2 rigosertib
39 Pembrolizumab in Refractory Metastatic Anal Cancer Recruiting NCT02919969 Phase 2 Pembrolizumab
40 Proton Therapy in Reducing Toxicity in Anal Cancer Recruiting NCT03018418 Phase 2 Chemotherapy
41 Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer Recruiting NCT02865135 Phase 1, Phase 2 DPX-E7 vaccine
42 Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal Cancer Recruiting NCT03381352 Phase 2 Capecitabine;Mitomycin C
43 A Study of mDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal Carcinoma Recruiting NCT03519295 Phase 2 MPDL3280A;mDCF
44 Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer Recruiting NCT03233711 Phase 2
45 VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2 Recruiting NCT03499795 Phase 2
46 LET-IMPT and Standard Chemotherapy in Treating Patients With Newly Diagnosed Stage I-III Anal Canal Squamous Cell Cancer Recruiting NCT03690921 Phase 2 Cisplatin;Fluorouracil
47 M7824 in Subjects With HPV Associated Malignancies Recruiting NCT03427411 Phase 2 M7824
48 Study of SIB-IMRT in Combination With 5-FU and Mitomycin-C Among Patients With Locally Advanced Anal Canal Cancer: Efficacy, Safety and Quality of Life Recruiting NCT02701088 Phase 2 5Fluorouracile and Mitomycin-C
49 A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal Wand Recruiting NCT03302858 Phase 2
50 Avelumab With Valproic Acid in Virus-associated Cancer Recruiting NCT03357757 Phase 2 Valproic Acid

Search NIH Clinical Center for Anus Cancer

Cochrane evidence based reviews: anus neoplasms

Genetic Tests for Anus Cancer

Anatomical Context for Anus Cancer

MalaCards organs/tissues related to Anus Cancer:

Testes, Lymph Node, Skin, Colon, Liver, Bone, Bone Marrow

The Foundational Model of Anatomy Ontology organs/tissues related to Anus Cancer:

The Anus

Publications for Anus Cancer

Articles related to Anus Cancer:

(show top 50) (show all 780)
# Title Authors Year
HPV-Associated Anal Cancer in the HIV/AIDS Patient. ( 30523625 )
Reduction in social activities mediates the relationship between diarrhea and distress in rectal/anal cancer survivors. ( 28665010 )
Transperineal retropubic approach in total pelvic exenteration for advanced and recurrent colorectal and anal cancer involving the penile base: technique and outcomes. ( 30306276 )
Anal cancer in high-income countries: Increasing burden of disease. ( 30339668 )
Recent advances in the management of anal cancer. ( 30345012 )
Health Care Costs of Anal Cancer in a Commercially Insured Population in the United States. ( 30362917 )
Experimental and investigational drugs for the treatment of anal cancer. ( 30381968 )
ASO Author Reflections: Salvage Surgery for Anal Cancer. ( 30414037 )
Anal Cancer: Putting Health-Related Quality of Life at the Forefront. ( 30415785 )
Association of anal symptoms with anal high grade squamous intraepithelial lesions (HSIL) among men who have sex with men: Baseline data from the study of the prevention of anal cancer (SPANC). ( 30439602 )
Accuracy of Anal Cytology for Diagnostic of Precursor Lesions of Anal Cancer: Systematic Review and Meta-analysis. ( 30451747 )
Dosimetric comparison of different radiation techniques (IMRT vs. 3-dimensional) of the "true" (deep) ano-inguinal lymphatic drainage of anal cancer patients. ( 30466454 )
Effect of an Educational Video to Increase Calls and Screening into an Anal Cancer Clinical Trial Among HIV+ Hispanics in PR: Results from a Randomized Controlled Behavioral Trial. ( 30467711 )
Toxicity and survival of anal cancer patients treated with intensity-modulated radiation therapy. ( 30482037 )
Chemoradiation in female patients with anal cancer: Patient-reported outcome of acute and chronic side effects. ( 30484384 )
A core outcome set for clinical trials of chemoradiotherapy interventions for anal cancer (CORMAC): a patient and health-care professional consensus. ( 30507470 )
Incorporating digital anorectal examinations for anal cancer screening into routine HIV care for men who have sex with men living with HIV: a prospective cohort study. ( 30516346 )
Factors associated with self-reported anal cancer screening history in men who have sex with men. ( 30517839 )
Sociodemographic Predictors of Anal Cancer Screening and Follow-up in Human Immunodeficiency Virus-Infected Individuals. ( 28723723 )
A phase II clinical study to assess the feasibility of self and partner anal examinations to detect anal canal abnormalities including anal cancer. ( 28835533 )
Image-guided IMRT with simultaneous integrated boost as per RTOG 0529 for the treatment of anal cancer. ( 28856848 )
Prevalence of patient-reported gastrointestinal symptoms and agreement with clinician toxicity assessments in radiation therapy for anal cancer. ( 28884454 )
The volume of PET-defined, active bone marrow spared predicts acute hematologic toxicities in anal cancer patients receiving concurrent chemoradiotherapy. ( 28903619 )
Differences in the Immune Microenvironment of Anal Cancer Precursors by HIV Status and Association With Ablation Outcomes. ( 28968881 )
Effect of CD4 Count on Treatment Toxicity and Tumor Recurrence in Human Immunodeficiency Virus-Positive Patients With Anal Cancer. ( 29102276 )
Anal Cancer Risk Among People With HIV Infection in the United States. ( 29140774 )
The importance of HPV16 in anal cancer prevention. ( 29158103 )
Barriers to participation in a sexual health intervention for men following treatment for rectal and anal cancer. ( 29172234 )
High prevalence and incidence of HPV-related anal cancer precursor lesions in HIV-positive women in the late HAART era. ( 29208455 )
Phase I-III development of the EORTC QLQ-ANL27, a health-related quality of life questionnaire for anal cancer. ( 29217122 )
Dosimetric quantification of the incidental irradiation of the 'true' (deep) ano-inguinal lymphatic drainage of anal cancer patients not described in conventional contouring guidelines. ( 29297232 )
Target volume motion during anal cancer image guided radiotherapy using cone-beam computed tomography. ( 29393674 )
Pre-treatment magnetic resonance-based texture features as potential imaging biomarkers for predicting event free survival in anal cancer treated by chemoradiotherapy. ( 29404766 )
Modern intensity-modulated radiotherapy with image guidance allows low toxicity rates and good local control in chemoradiotherapy for anal cancer patients. ( 29441419 )
Anal sphincter dysfunction in patients treated with primary radiotherapy for anal cancer: a study with the functional lumen imaging probe. ( 29447025 )
Primary Care Provider Practices and Perceptions Regarding HPV Vaccination and Anal Cancer Screening at a Boston Community Health Center. ( 29480339 )
Deviations From Standard Chemoradiation Among Early-Stage Anal Cancer Patients. ( 29485073 )
HIV-positive MSM's knowledge of HPV and anal cancer self-sampling: A scoping review. ( 29507499 )
Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapy. ( 29522569 )
Impact of socioeconomic status on survival for patients with anal cancer. ( 29527660 )
Systematic review of outcome measures following chemoradiotherapy for the treatment of anal cancer (CORMAC). ( 29566456 )
Outcome of surgery for recurrent anal cancer: results from a tertiary referral centre. ( 29573536 )
Genital marginal failures after intensity-modulated radiation therapy (IMRT) in squamous cell anal cancer: no higher risk with IMRT when compared to 3DCRT. ( 29594584 )
Treatment of Anal Cancer Pain-A Case Report. ( 29608933 )
E5 can be expressed in anal cancer and leads to epidermal growth factor receptor-induced invasion in a human papillomavirus 16-transformed anal epithelial cell line. ( 29624161 )
Risk of Anal Cancer in Women With a Human Papillomavirus-Related Gynecological Neoplasm: Puerto Rico 1987-2013. ( 29649025 )
Salvage Abdominoperineal Resection for Squamous Cell Anal Cancer: A 30-Year Single-Institution Experience. ( 29691737 )
Anal cytological lesions and HPV infection in individuals at increased risk for anal cancer. ( 29694716 )
Abnormal neuronal response to rectal and anal stimuli in patients treated with primary radiotherapy for anal cancer. ( 29706461 )
Limitations of the National Cancer Data Base to Evaluate Early-Stage Anal Cancer Treatment Outcomes. ( 29710110 )

Variations for Anus Cancer

Expression for Anus Cancer

Search GEO for disease gene expression data for Anus Cancer.

Pathways for Anus Cancer

GO Terms for Anus Cancer

Sources for Anus Cancer

9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
32 HPO
33 ICD10
34 ICD10 via Orphanet
38 LifeMap
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
55 Novoseek
58 OMIM via Orphanet
62 PubMed
70 SNOMED-CT via Orphanet
72 Tocris
74 UMLS via Orphanet
Loading form....